• Clinical Evidence

Hypoglycemia with Intensive Insulin Therapy After Cardiac Surgery: Predisposing Factors and Association with Mortality

Setting: Heart and vascular institute of an 874-bed regional academic medical center.

Objective

This retrospective cohort study (using prospectively collected data) compares major morbidity, operative mortality and actuarial survival of hypoglycemic cardiac surgery patients to normoglycemic cardiac surgery patients (all of whom received intensive insulin therapy managed with EndoTool).

Setting

Heart and vascular institute of an 874-bed regional academic medical center.

Results

  • Hypoglycemic patients were more likely to receive intraoperative blood products than normoglycemic patients (66% vs 37%) and experienced higher rates of hemorrhage-related reexploration (14% vs 4.9%), acute renal failure (14% vs 4.1%), stroke (10% vs 1.4%), reintubation (25% vs 5.4%), prolonged ventilatory support (39% vs 10.2%), pneumonia (17% vs 3.5%) and hemodialysis (5% vs 1.2%).
  • Median hospital length of stay was considerably longer for hypoglycemic patients than for normoglycemic patients (14 vs 9 days) as was intensive care unit length of stay (4.9 vs 1.7 days).
  • Hypoglycemic patients had a higher risk of operative mortality than normoglycemic patients in a univariate analysis (10% vs 2%), but not in a propensity score adjusted analysis.
  • Hypoglycemic and normoglycemic patients had a similar 5-year actuarial survival (75%).

Conclusions

Hypoglycemia with intensive insulin therapy is independently associated with increased risk of major morbidity and prolonged hospital and intensive care unit lengths of stay after cardiac surgery; it is hypothesized that a higher target level of blood glucose in the post-operative period may decrease the frequency of hypoglycemia episodes and thereby reduce risk of major morbidity, and a more focused and individualized approach may be warranted for patients with diabetes, female patients and patients with renal failure.

Objective

This retrospective cohort study (using prospectively collected data) compares major morbidity, operative mortality and actuarial survival of hypoglycemic cardiac surgery patients to normoglycemic cardiac surgery patients (all of whom received intensive insulin therapy managed with EndoTool).

Setting

Heart and vascular institute of an 874-bed regional academic medical center.

Results
  • Hypoglycemic patients were more likely to receive intraoperative blood products than normoglycemic patients (66% vs 37%) and experienced higher rates of hemorrhage-related reexploration (14% vs 4.9%), acute renal failure (14% vs 4.1%), stroke (10% vs 1.4%), reintubation (25% vs 5.4%), prolonged ventilatory support (39% vs 10.2%), pneumonia (17% vs 3.5%) and hemodialysis (5% vs 1.2%).
  • Median hospital length of stay was considerably longer for hypoglycemic patients than for normoglycemic patients (14 vs 9 days) as was intensive care unit length of stay (4.9 vs 1.7 days).
  • Hypoglycemic patients had a higher risk of operative mortality than normoglycemic patients in a univariate analysis (10% vs 2%), but not in a propensity score adjusted analysis.
  • Hypoglycemic and normoglycemic patients had a similar 5-year actuarial survival (75%).
Conclusions

Hypoglycemia with intensive insulin therapy is independently associated with increased risk of major morbidity and prolonged hospital and intensive care unit lengths of stay after cardiac surgery; it is hypothesized that a higher target level of blood glucose in the post-operative period may decrease the frequency of hypoglycemia episodes and thereby reduce risk of major morbidity, and a more focused and individualized approach may be warranted for patients with diabetes, female patients and patients with renal failure.

References

Authors

Sotiris Stamou, MD, PhD; Marcy Nussbaum, MS; John Carew, PhD, MS; Kelli Dunn, MD; Eric Skipper, MD; Francis Robicsek, MD, PhD; Kevin Lobdell, MD.

Source

Published in The Journal of Thoracic and Cardiovascular Surgery, Volume 142, Number 1, p166-173.

Year

2011

Objective

This retrospective cohort study (using prospectively collected data) compares major morbidity, operative mortality and actuarial survival of hypoglycemic cardiac surgery patients to normoglycemic cardiac surgery patients (all of whom received intensive insulin therapy managed with EndoTool).

Setting

Heart and vascular institute of an 874-bed regional academic medical center.

Results
  • Hypoglycemic patients were more likely to receive intraoperative blood products than normoglycemic patients (66% vs 37%) and experienced higher rates of hemorrhage-related reexploration (14% vs 4.9%), acute renal failure (14% vs 4.1%), stroke (10% vs 1.4%), reintubation (25% vs 5.4%), prolonged ventilatory support (39% vs 10.2%), pneumonia (17% vs 3.5%) and hemodialysis (5% vs 1.2%).
  • Median hospital length of stay was considerably longer for hypoglycemic patients than for normoglycemic patients (14 vs 9 days) as was intensive care unit length of stay (4.9 vs 1.7 days).
  • Hypoglycemic patients had a higher risk of operative mortality than normoglycemic patients in a univariate analysis (10% vs 2%), but not in a propensity score adjusted analysis.
  • Hypoglycemic and normoglycemic patients had a similar 5-year actuarial survival (75%).
Conclusions

Hypoglycemia with intensive insulin therapy is independently associated with increased risk of major morbidity and prolonged hospital and intensive care unit lengths of stay after cardiac surgery; it is hypothesized that a higher target level of blood glucose in the post-operative period may decrease the frequency of hypoglycemia episodes and thereby reduce risk of major morbidity, and a more focused and individualized approach may be warranted for patients with diabetes, female patients and patients with renal failure.

References

Authors

Sotiris Stamou, MD, PhD; Marcy Nussbaum, MS; John Carew, PhD, MS; Kelli Dunn, MD; Eric Skipper, MD; Francis Robicsek, MD, PhD; Kevin Lobdell, MD.

Source

Published in The Journal of Thoracic and Cardiovascular Surgery, Volume 142, Number 1, p166-173.

Year

2011

Short and Sweet Headlines are Best!

Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.